Condition
Unresectable Gastroesophageal Junction Adenocarcinoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Unresectable Gastroesophageal Junction Adenocarcinoma clinical trials that are recruiting, at sites in 2 countries (most in United States (5), Puerto Rico (1)). By phase: Phase 1 (1), Phase 1/2 (1), Phase 2/3 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest Unresectable Gastroesophageal Junction Adenocarcinoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining two anticancer drugs for treating advanced gastric and gastroesophageal junction cancers | Phase 1 | Houston, Texas | Recruiting | Apr 15, 2024 |
| Combining Nivolumab with Standard Treatment for Advanced Stomach or Esophageal Cancer | Phase 2/3 | Little Rock, Arkansas and 377 other locations | Recruiting | Jan 12, 2024 |
| Comparing two chemotherapy regimens for advanced HER2 negative gastric and esophageal cancer | Phase 3 | Birmingham, Alabama and 801 other locations | Recruiting | Jan 10, 2023 |
| Using propranolol with pembrolizumab and chemotherapy for advanced esophageal cancer | Phase 2 | Buffalo, New York | Recruiting | Dec 15, 2022 |
| Personalized vaccine combined with pembrolizumab for advanced solid tumors | Phase 1/2 | Jacksonville, Florida | Recruiting | Mar 8, 2022 |
All recruiting trials (5)
-
Combining two anticancer drugs for treating advanced gastric and gastroesophageal junction cancers
This study is testing a new combination of two cancer drugs to see if they can help people with advanced HER2-positive gastric or gastroesophageal junction cancers feel better and live longer.
-
Combining Nivolumab with Standard Treatment for Advanced Stomach or Esophageal Cancer
This study is testing if adding nivolumab to the usual treatments for advanced stomach or esophageal cancer can help patients live longer and feel better.
-
Comparing two chemotherapy regimens for advanced HER2 negative gastric and esophageal cancer
This study is testing if a new chemotherapy combination can help people with advanced HER2 negative stomach and esophageal cancer live longer compared to the standard treatment.
-
Using propranolol with pembrolizumab and chemotherapy for advanced esophageal cancer
This study is testing whether adding propranolol to the cancer drug pembrolizumab and standard chemotherapy can help people with advanced esophageal cancer live longer and feel better.
-
Personalized vaccine combined with pembrolizumab for advanced solid tumors
This study is testing a new personalized cancer vaccine combined with pembrolizumab to see if it helps people with advanced solid tumors fight their cancer better.
Related topics
Quick answers
How many Unresectable Gastroesophageal Junction Adenocarcinoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (5 trials), Puerto Rico (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1, Phase 2/3: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.